$ICUI
ICU MEDICAL INC/DE Stock $icui

$icui Overview Financials Valuation SEC Filings Company Website

2012 Q1 Form 10-Q Financial Statement

#000088398412000060 Filed on April 20, 2012

Income Statement

Concept	2012 Q1	2011 Q1
Revenue	$75.51M	$71.47M
YoY Change	5.65%	12.16%
Cost Of Revenue	$40.55M	$36.85M
YoY Change	10.04%	-1.48%
Gross Profit	$34.97M	$34.63M
YoY Change	0.98%	31.72%
Gross Profit Margin	46.3%	48.45%
Selling, General & Admin	$20.89M	$22.86M
YoY Change	-8.63%	16.06%
% of Gross Profit	59.75%	66.03%
Research & Development	$2.693M	$2.052M
YoY Change	31.24%	128.0%
% of Gross Profit	7.7%	5.93%
Depreciation & Amortization	$4.777M	$4.500M
YoY Change	6.16%	-2.17%
% of Gross Profit	13.66%	13.0%
Operating Expenses	$23.58M	$22.42M
YoY Change	5.21%	8.81%
Operating Profit	$11.38M	$12.21M
YoY Change	-6.79%	114.72%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$135.0K	$403.0K
YoY Change	-66.5%	101.5%
Pretax Income	$11.52M	$12.61M
YoY Change	-8.7%	94.06%
Income Tax	$3.916M	$4.541M
% Of Pretax Income	34.0%	36.0%
Net Earnings	$7.601M	$8.073M
YoY Change	-5.85%	109.2%
Net Earnings / Revenue	10.07%	11.3%
Basic Earnings Per Share	$0.54	$0.59
Diluted Earnings Per Share	$0.53	$0.57
COMMON SHARES
Basic Shares Outstanding	13.96M shares	13.69M shares
Diluted Shares Outstanding	14.32M shares	14.06M shares

Balance Sheet

Concept	2012 Q1	2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$183.6M	$106.8M
YoY Change	71.91%	25.8%
Cash & Equivalents	$122.1M	$71.11M
Short-Term Investments	$61.50M	$35.70M
Other Short-Term Assets	$9.700M	$14.30M
YoY Change	-32.17%	36.19%
Inventory	$37.29M	$51.20M
Prepaid Expenses
Receivables	$41.73M	$50.60M
Other Receivables	$3.700M	$0.00
Total Short-Term Assets	$276.0M	$223.0M
YoY Change	23.76%	22.66%
LONG-TERM ASSETS
Property, Plant & Equipment	$83.18M	$85.90M
YoY Change	-3.16%	3.87%
Goodwill	$1.478M
YoY Change
Intangibles	$11.07M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.800M	$4.600M
YoY Change	4.35%	24.32%
Total Long-Term Assets	$100.5M	$106.2M
YoY Change	-5.37%	1.05%
TOTAL ASSETS
Total Short-Term Assets	$276.0M	$223.0M
Total Long-Term Assets	$100.5M	$106.2M
Total Assets	$376.5M	$329.2M
YoY Change	14.36%	14.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.83M	$13.80M
YoY Change	-14.31%	-23.33%
Accrued Expenses	$13.56M	$12.70M
YoY Change	6.79%	9.48%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$25.39M	$27.60M
YoY Change	-8.02%	-11.25%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$4.100M	$4.200M
YoY Change	-2.38%	-12.5%
Total Long-Term Liabilities	$4.100M	$4.200M
YoY Change	-2.38%	-12.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$25.39M	$27.60M
Total Long-Term Liabilities	$4.100M	$4.200M
Total Liabilities	$36.60M	$39.80M
YoY Change	-8.04%	-4.1%
SHAREHOLDERS EQUITY
Retained Earnings	$308.5M
YoY Change
Common Stock	$59.59M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$27.03M
YoY Change
Treasury Stock Shares	738.0K shares
Shareholders Equity	$339.9M	$289.4M
YoY Change
Total Liabilities & Shareholders Equity	$376.5M	$329.2M
YoY Change	14.36%	14.74%

Cashflow Statement

Concept	2012 Q1	2011 Q1
OPERATING ACTIVITIES
Net Income	$7.601M	$8.073M
YoY Change	-5.85%	109.2%
Depreciation, Depletion And Amortization	$4.777M	$4.500M
YoY Change	6.16%	-2.17%
Cash From Operating Activities	$18.34M	$15.17M
YoY Change	20.89%	48.7%
INVESTING ACTIVITIES
Capital Expenditures	$3.632M	$4.942M
YoY Change	-26.51%	-147.52%
Acquisitions
YoY Change
Other Investing Activities	-$1.000M	-$21.20M
YoY Change	-95.28%	-239.47%
Cash From Investing Activities	-$4.891M	-$26.17M
YoY Change	-81.31%	-645.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$8.391M	$2.216M
YoY Change	278.66%	-109.55%
NET CHANGE
Cash From Operating Activities	$18.34M	$15.17M
Cash From Investing Activities	-$4.891M	-$26.17M
Cash From Financing Activities	$8.391M	$2.216M
Net Change In Cash	$21.84M	-$8.785M
YoY Change	-348.56%	7.13%
FREE CASH FLOW
Cash From Operating Activities	$18.34M	$15.17M
Capital Expenditures	$3.632M	$4.942M
Free Cash Flow	$14.70M	$10.23M
YoY Change	43.8%	-50.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	13251000	USD
CY2012Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	11825000	USD
CY2011Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	43571000	USD
CY2012Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	41728000	USD
CY2012Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	13562000	USD
CY2011Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	16059000	USD
CY2012Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	103607000	USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	99902000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3234000	USD
CY2012Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1147000	USD
CY2011Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	56796000	USD
CY2012Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	58106000	USD
CY2011Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1293000	USD
CY2012Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1056000	USD
CY2012Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	141000	shares
CY2011Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	135000	shares
CY2012Q1	us-gaap	Assets Assets	376484000	USD
CY2011Q4	us-gaap	Assets Assets	361112000	USD
CY2012Q1	us-gaap	Assets Current AssetsCurrent	275991000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	260408000	USD
CY2012Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	61482000	USD
CY2011Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	60395000	USD
CY2012Q1	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
CY2011Q1	us-gaap	Available For Sale Securities Gross Realized Gain Loss Net AvailableForSaleSecuritiesGrossRealizedGainLossNet	0	USD
CY2012Q1	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	0	USD
CY2011Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	0	USD
CY2011Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2012Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	588000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	99590000	USD
CY2012Q1	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">New Accounting Pronouncements:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;padding-bottom:6px;padding-top:6px;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div>
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	122103000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78850000	USD
CY2011Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	71114000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	22513000	USD
CY2011Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-7736000	USD
CY2011Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	159985000	USD
CY2012Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	183585000	USD
CY2012Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	100.00
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	100.00
CY2012Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2012Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14855000	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14855000	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13871000	shares
CY2012Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14117000	shares
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	1486000	USD
CY2012Q1	us-gaap	Common Stock Value CommonStockValue	1486000	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	9688000	USD
CY2011Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	11942000	USD
CY2012Q1	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2011Q4	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue	0	USD
CY2012Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	40546000	USD
CY2011Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	36845000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	4081000	USD
CY2012Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	3798000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	4759000	USD
CY2012Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	4767000	USD
CY2011Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	7144000	USD
CY2012Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	7127000	USD
CY2011Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4500000	USD
CY2012Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4777000	USD
CY2011Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
CY2011Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.57
CY2012Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	677000	USD
CY2011Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	1049000	USD
CY2012Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.34
CY2011Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.36
CY2012Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1626000	USD
CY2011Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	280000	USD
CY2012Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-27000	USD
CY2011Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2011Q1	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	2500000	USD
CY2012Q1	us-gaap	Goodwill Goodwill	1478000	USD
CY2011Q4	us-gaap	Goodwill Goodwill	1478000	USD
CY2011Q1	us-gaap	Gross Profit GrossProfit	34626000	USD
CY2012Q1	us-gaap	Gross Profit GrossProfit	34965000	USD
CY2011Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	12614000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	11517000	USD
CY2011Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4541000	USD
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3916000	USD
CY2011Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2764000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1610000	USD
CY2011Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5085000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1931000	USD
CY2011Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2091000	USD
CY2012Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2608000	USD
CY2011Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-278000	USD
CY2012Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	0	USD
CY2011Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6186000	USD
CY2012Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3768000	USD
CY2011Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	252000	USD
CY2012Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-898000	USD
CY2011Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	364000	shares
CY2012Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	362000	shares
CY2011Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11419000	USD
CY2012Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	11065000	USD
CY2011Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	12295000	USD
CY2012Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11505000	USD
CY2012Q1	us-gaap	Inventory Net InventoryNet	37290000	USD
CY2011Q4	us-gaap	Inventory Net InventoryNet	40423000	USD
CY2011Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	25227000	USD
CY2012Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	21924000	USD
CY2011Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2901000	USD
CY2012Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	3861000	USD
CY2012Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	357000	USD
CY2011Q1	us-gaap	Investment Income Amortization Of Premium InvestmentIncomeAmortizationOfPremium	19000	USD
CY2012Q1	us-gaap	Legal Fees LegalFees	0	USD
CY2011Q1	us-gaap	Legal Fees LegalFees	-2500000	USD
CY2012Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	376484000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	361112000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29310000	USD
CY2012Q1	us-gaap	Liabilities Current LiabilitiesCurrent	25387000	USD
CY2011Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	4081000	USD
CY2012Q1	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	4081000	USD
CY2011Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2216000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8391000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4891000	USD
CY2011Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26168000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	18336000	USD
CY2011Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15167000	USD
CY2012Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	135000	USD
CY2011Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	403000	USD
CY2011Q1	us-gaap	Operating Expenses OperatingExpenses	22415000	USD
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	23583000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	11382000	USD
CY2011Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	12211000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	2087000	USD
CY2011Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease	3869000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	295000	USD
CY2011Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	176000	USD
CY2012Q1	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	128000	USD
CY2011Q1	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	133000	USD
CY2012Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2011Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2011Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2012Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-287000	USD
CY2012Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	22424000	USD
CY2011Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	24530000	USD
CY2012Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3632000	USD
CY2011Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4942000	USD
CY2012Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1000.00
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1000.00
CY2012Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2011Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6759000	USD
CY2012Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5913000	USD
CY2011Q4	us-gaap	Prepaid Taxes PrepaidTaxes	5589000	USD
CY2012Q1	us-gaap	Prepaid Taxes PrepaidTaxes	3677000	USD
CY2011Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	3304000	USD
CY2012Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	21442000	USD
CY2011Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2012Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	10000	USD
CY2012Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5684000	USD
CY2011Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1027000	USD
CY2012Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1081000	USD
CY2011Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	909000	USD
CY2011Q1	us-gaap	Profit Loss ProfitLoss	8073000	USD
CY2012Q1	us-gaap	Profit Loss ProfitLoss	7601000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	182950000	USD
CY2012Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	186790000	USD
CY2012Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	83183000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	83048000	USD
CY2011Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	208000	USD
CY2012Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-263000	USD
CY2012Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2693000	USD
CY2011Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2052000	USD
CY2012Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	308478000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	300877000	USD
CY2012Q1	us-gaap	Revenues Revenues	75511000	USD
CY2011Q1	us-gaap	Revenues Revenues	71471000	USD
CY2012Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	75383000	USD
CY2011Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	71338000	USD
CY2012Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20890000	USD
CY2011Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	22863000	USD
CY2011Q1	us-gaap	Share Based Compensation ShareBasedCompensation	978000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1231000	USD
CY2012Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	339889000	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	320577000	USD
CY2011Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	984000	shares
CY2012Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	738000	shares
CY2011Q4	us-gaap	Treasury Stock Value TreasuryStockValue	35348000	USD
CY2012Q1	us-gaap	Treasury Stock Value TreasuryStockValue	27034000	USD
CY2011Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14056000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14318000	shares
CY2011Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13692000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13956000	shares
CY2012Q1	icui	Debt Securities Callable Period DebtSecuritiesCallablePeriod	1Y
CY2012Q1	icui	Debt Securities Maturity Date Range High DebtSecuritiesMaturityDateRangeHigh	2042
CY2012Q1	icui	Debt Securities Maturity Date Range Low DebtSecuritiesMaturityDateRangeLow	2012
CY2011Q1	icui	Increase Decrease In Prepaid And Deferred Income Taxes IncreaseDecreaseInPrepaidAndDeferredIncomeTaxes	2347000	USD
CY2012Q1	icui	Increase Decrease In Prepaid And Deferred Income Taxes IncreaseDecreaseInPrepaidAndDeferredIncomeTaxes	1915000	USD
CY2011Q1	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	0	USD
CY2012Q1	icui	Provision For Warranty And Returns ProvisionForWarrantyAndReturns	312000	USD
CY2012Q1	dei	Amendment Flag AmendmentFlag	false
CY2012Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2012Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2012Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
CY2012Q1	dei	Document Period End Date DocumentPeriodEndDate	2012-03-31
CY2012Q1	dei	Document Type DocumentType	10-Q
CY2012Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000883984
CY2012Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14142066	shares
CY2012Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2012Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2012Q1	dei	Entity Registrant Name EntityRegistrantName	ICU MEDICAL INC/DE

Files In Submission

Name	View Source	Status
0000883984-12-000060-index-headers.html	Edgar Link	pending
0000883984-12-000060-index.html	Edgar Link	pending
0000883984-12-000060.txt	Edgar Link	pending
0000883984-12-000060-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
icui-20120331.xml	Edgar Link	completed
icui-20120331.xsd	Edgar Link	pending
icui-20120331_cal.xml	Edgar Link	unprocessable
icui-20120331_def.xml	Edgar Link	unprocessable
icui-20120331_lab.xml	Edgar Link	unprocessable
icui-20120331_pre.xml	Edgar Link	unprocessable
icui-ex311_20120331x10q.htm	Edgar Link	pending
icui-ex312_20120331x10xq.htm	Edgar Link	pending
icui-ex321_20120331x10q.htm	Edgar Link	pending
icui0331201210-q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICUI
ICU MEDICAL INC/DE Stock $icui

2012 Q1 Form 10-Q Financial Statement

#000088398412000060 Filed on April 20, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI ICU MEDICAL INC/DE Stock $icui

2012 Q1 Form 10-Q Financial Statement

#000088398412000060 Filed on April 20, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICUI
ICU MEDICAL INC/DE Stock $icui